Comparison of the efficacy and tolerability of BCG with and without interferon alpha 2b and/or megadose vitamin [Oncovite] supplements as adjuvant therapy in patients with non-muscle invasive bladder cancer (Ta, T1, or carcinoma in situ) who have received no prior BCG treatment for bladder cancer.
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2011
At a glance
- Drugs BCG; Interferon alpha-2b; Vitamins
- Indications Bladder cancer
- Focus Therapeutic Use
- 08 Feb 2011 New trial record